Global

Life Sciences 

KPMG’s global Life Sciences practice is dedicated to assisting businesses of all sizes from biotechnology start-ups to large multinational pharmaceutical companies.

More than medicine

More than medicine
More than medicine examines strategies and emerging opportunities life sciences companies can use to align their interests and expertise to evolving healthcare systems.

The agricultural and food value chain - Entering a new era of cooperation

Agricultural and food value chain
This report explores the complex challenges facing the agricultural and food industry, such as climate change, technological innovation and demand for greater transparency.

Issues monitor: Pharmaceuticals

Issues monitor Pharmaceuticals
Each edition of Issues monitor pulls together to help you quickly and easily get briefed on issues impacting the pharmaceuticals sector.

Chris Stirling

Chris Stirling

Global Chair, Life Sciences

+44 20 73118512

Our services are tailored to the issues that the industry ― and your company ― experience. Our member firms’ professionals have already helped many companies with these issues:

 

  • sales force compliance
  • pricing compliance
  • business model operating structure
  • operational efficiency
  • change management
  • supply chain management
  • fraud and intellectual property
  • innovation and research and development
  • competition from generics
  • mergers, acquisitions and disposals
  • market entry and expansion
  • emerging market companies.

 

KPMG’s industry-focused professionals have experience in the pharmaceutical sector; they continuously strive to keep abreast of industry trends, drivers and issues through knowledge sharing and industry insights programs. Our global network aims to ensure that KPMG firms serve you with the same level of quality and consideration, whether you are operating in fast growing or emerging markets in the Americas, Asia or Europe.